Plasma corticotrophin releasing factor and vasopressin responses to exercise in normal man. 1991

G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
Department of Endocrinology, Princess Margaret Hospital, Christchurch, New Zealand.

OBJECTIVE To evaluate the hypothalamo-pituitary-adrenal (HPA) response to both mild and intense exercise. METHODS Maximum oxygen consumption (VO2max.) was initially determined. Exercise to 20% (mild) and 90% (intense) VO2max. was undertaken in random order. Subjects were exercised over a 5-minute period to the required level of intensity, which was maintained for a further 10 minutes. METHODS Six trained male athletes. METHODS Brachial vein blood was sampled before and at 5-minute intervals during and after exercise and assayed for plasma cortisol, ACTH, arginine vasopressin (AVP), corticotrophin releasing factor (CRF), sodium and lactate levels. Haemoglobin and haematocrit were measured before and at the end of exercise. Heart rate was monitored continuously and blood pressure measured whenever blood was sampled before and after exercise. RESULTS Maximum heart rate was 184 +/- 2 and 82 +/- 5 (mean +/- SEM) beats per minute at 90 and 20% VO2max. respectively. Plasma volume fell by 8.7 +/- 2.4% with intense exercise. Significant increases in plasma concentrations of AVP, ACTH and cortisol, but not CRF, occurred during intense exercise. Plasma sodium concentration, which increased during intense but not mild exercise, peaked at 10 minutes after the onset of exercise and preceded the rise in plasma AVP. The AVP peak clearly preceded the ACTH peak in two subjects and occurred synchronously with it in three subjects. CONCLUSIONS These results indicate that although significant HPA activation occurs during intense exercise, CRF does not appear to play a major role in mediating the ACTH response to an acute episode of vigorous exercise in man. AVP may be more important in this regard.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23

Related Publications

G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
January 1990, Clinical endocrinology,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
January 1986, Acta endocrinologica,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
September 1992, The Journal of clinical endocrinology and metabolism,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
October 1988, British journal of obstetrics and gynaecology,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
January 1984, Clinical endocrinology,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
April 1994, Clinical endocrinology,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
March 1979, Nature,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
September 1988, The Journal of physiology,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
February 1998, Endocrine,
G A Wittert, and D E Stewart, and M P Graves, and M J Ellis, and M J Evans, and J E Wells, and R A Donald, and E A Espiner
April 1987, The Journal of endocrinology,
Copied contents to your clipboard!